Developing routinely recorded clinical data from electronic patient records as a national resource to improve neonatal health care: the medicines for neonates …
Background Clinical data offer the potential to advance patient care. Neonatal specialised
care is a high-cost NHS service received by approximately 80,000 newborn infants each …
care is a high-cost NHS service received by approximately 80,000 newborn infants each …
Standardisation of the Parent Report of Children's Abilities–Revised (PARCA-R): a norm-referenced assessment of cognitive and language development at age 2 …
Summary Background The Parent Report of Children's Abilities–Revised (PARCA-R) can be
used to identify preterm born children at risk for developmental delay at age 24 months …
used to identify preterm born children at risk for developmental delay at age 24 months …
[HTML][HTML] Is European Medicines Agency (EMA) sepsis criteria accurate for neonatal sepsis diagnosis or do we need new criteria?
Background Currently, there is a lack of clear definition for neonatal sepsis. The Pediatric
Committee of the European Medicines Agency (EMA) developed consensus criteria to …
Committee of the European Medicines Agency (EMA) developed consensus criteria to …
[HTML][HTML] Effects of immunotherapy on mortality in neonates with suspected or proven sepsis: a systematic review and network meta-analysis
Y Li, S Yang, G Wang, M Liu, Z Zhang, H Liu, K Yu… - BMC pediatrics, 2019 - Springer
Background To investigate the efficacies of different immunotherapies in neonates with
suspected or proven sepsis. Methods We searched the Cochrane Library, EMBASE …
suspected or proven sepsis. Methods We searched the Cochrane Library, EMBASE …
Pathology and telepathology methods in the child health and mortality prevention surveillance network
RB Martines, JM Ritter, J Gary, WJ Shieh… - Clinical Infectious …, 2019 - academic.oup.com
This manuscript describes the Child Health and Mortality Prevention Surveillance
(CHAMPS) network approach to pathologic evaluation of minimally invasive tissue sampling …
(CHAMPS) network approach to pathologic evaluation of minimally invasive tissue sampling …
The WHEAT pilot trial—WithHolding Enteral feeds Around packed red cell Transfusion to prevent necrotising enterocolitis in preterm neonates: a multicentre …
Introduction Necrotising enterocolitis (NEC) is a potentially devastating neonatal disease. A
temporal association between red cell transfusion and NEC is well described. Observational …
temporal association between red cell transfusion and NEC is well described. Observational …
Rapid diagnosis of neonatal sepsis by PCR for detection of 16S rRNA gene, while blood culture and PCR results were similar in E.coli-predominant EOS cases
MI El-Amir, MA El-Feky, DA Abo Elwafa… - Infection and Drug …, 2019 - Taylor & Francis
Purpose To determine the bacteriological pattern and antibiotic susceptibility of bacterial
isolates causing neonatal sepsis in Qena University Hospitals and compare polymerase …
isolates causing neonatal sepsis in Qena University Hospitals and compare polymerase …
Bakterielle Infektionen bei Neugeborenen. Leitlinie der GNPI, DGPI, DGKJ und DGGG.(S2k-Level, AWMF-Leitlinien-Register-Nr. 024/008, April 2018)
Bei der Überarbeitung der Leitlinie wurden zwischen 2015 und 2017 die Datenbanken
MEDLINE (https://www. ncbi. nlm. nih. gov/pubmed/) und The Cochrane Library (http://www …
MEDLINE (https://www. ncbi. nlm. nih. gov/pubmed/) und The Cochrane Library (http://www …
Interleukin 17 is an important pathogenicity gene in pediatric sepsis
Y Han, X Li, S Gao, X Liu, L Kang, X Li… - Journal of Cellular …, 2019 - Wiley Online Library
Objective Sepsis represents a complex disease with the dysregulated inflammatory
response. The purpose of this study is to explore the role of interleukin 17 (IL‐17, also …
response. The purpose of this study is to explore the role of interleukin 17 (IL‐17, also …
Intravenous immunoglobin utilization study in a teaching hospital
N Rezaie, E Shajareh, MR Motamed… - Archives of Iranian …, 2019 - journalaim.com
Background: Intravenous immunoglobulin (IVIG) is an immunomodulating agent that has
several actions. The aim of this study was to investigate the indications of IVIG according to …
several actions. The aim of this study was to investigate the indications of IVIG according to …